Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Charles River Laboratories International, Inc.

< Previous 1 2 3 4 Next >
Charles River Laboratories Acquires SAMDI Tech
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches CliniPrime Suite of GMP-Compliant Cellular Products
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at November Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Third-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Expands Contract Vivarium Space on West Coast
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Second-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Announces First-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories Acquires Explora BioLabs
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
From Charles River Laboratories International, Inc.
Via Business Wire
Tickers CRL
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.